Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
VHI · NYSE · United States · Industrial Inorganic Chemicals
In shortVALHI INC /DE/ is loss-making, burns cash and carries moderate debt, with revenue stable (−1.3% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | 3.0% | 27/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -2.8% | 9/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -5.6% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | 3.1% | 21/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 2.80× | 100/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.58× | 79/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | 2.89× | 32/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | 1.11× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | 3.48 | 61/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -4.0% | 4/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 2 of 5 | 25/100 |
Weight in the score: 20%
| Profitable years (last 5) | 3 of 5 | 60/100 |
|---|---|---|
| Years of revenue decline (last 5) | 3 of 5 | 0/100 |
| Revenue growth volatility | 14.3% | 58/100 |
| Operating margin volatility | 5.2% | 62/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | -2.2% | 4/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 2,296 | 2,223 | 1,922 | 2,105 | 2,077 |
| Cost of revenue | 1,716 | 1,732 | 1,677 | 1,680 | 1,782 |
| Gross profit | 580 | 490 | 245 | 425 | 295 |
| Research & development | 17 | 16 | 18 | 14 | 17 |
| Selling, general & admin | 312 | 304 | 277 | 256 | 312 |
| Operating income | 319 | 239 | 34 | 211 | 63 |
| Interest expense | 33 | 28 | 28 | 50 | 57 |
| Pre-tax income | 258 | 170 | (20) | 244 | (43) |
| Income tax | 60 | 37 | (25) | 83 | 12 |
| Net income | 127 | 87 | (9.9) | 108 | (58) |
| Diluted EPS | $4.46 | $3.06 | −$0.35 | $3.79 | −$2.02 |
| Diluted shares (millions) | 29 | 0 | 0 | 0 | 0 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
3.48 Safe zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
4/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 6, 2026